Kenneth Bate Insider Trading Activity
Kenneth Bate has been net-selling over the last 12 months with 0 purchases and 17 sales across 1 company.
MDGL is the most-traded position with 17 trades. The largest single transaction was a sale of MDGL for $1.6M on Nov 5, 2025.
Performance Scorecard
Forward stock performance after each transaction by Kenneth Bate. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -18.0% | 0% | 17 |
| 90 days | — | -14.0% | 47% | 17 |
| 120 days | — | -12.6% | 65% | 17 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersMDGL · MADRIGAL PHARMACEUTICALS, INC.
🔒 Subscribe to see trade entries
Pro members see exactly when Kenneth Bate bought and sold MDGL.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Nov 5, 2025 | MDGL | Sell | 1,763 | $480.24 | $847K | −9.2% | Director | |
Nov 5, 2025 | MDGL | Sell | 3,259 | $481.13 | $1.6M | −18.7% | Director | |
Nov 5, 2025 | MDGL | Sell | 1,284 | $482.41 | $619K | −9.1% | Director | |
Nov 5, 2025 | MDGL | Sell | 2,069 | $483.41 | $1.0M | −16.0% | Director | |
Nov 5, 2025 | MDGL | Sell | 1,931 | $484.78 | $936K | −17.8% | Director | |
Nov 5, 2025 | MDGL | Sell | 1,008 | $485.54 | $489K | −11.3% | Director | |
Nov 5, 2025 | MDGL | Sell | 827 | $486.73 | $403K | −10.5% | Director | |
Nov 5, 2025 | MDGL | Sell | 2,775 | $487.49 | $1.4M | −39.3% | Director | |
Nov 5, 2025 | MDGL | Sell | 696 | $489.09 | $340K | −16.2% | Director | |
Nov 5, 2025 | MDGL | Sell | 933 | $489.95 | $457K | −26.0% | Director | |
Nov 5, 2025 | MDGL | Sell | 30 | $490.98 | $15K | −1.1% | Director | |
Aug 15, 2025 | MDGL | Sell | 2,317 | $363.41 | $842K | −18.3% | Director | |
Aug 15, 2025 | MDGL | Sell | 2,516 | $364.24 | $916K | −24.4% | Director | |
Aug 15, 2025 | MDGL | Sell | 2,567 | $365.33 | $938K | −32.9% | Director | |
Aug 15, 2025 | MDGL | Sell | 600 | $366.14 | $220K | −11.5% | Director | |
Aug 15, 2025 | MDGL | Sell | 1,104 | $367.63 | $406K | −23.9% | Director | |
Aug 15, 2025 | MDGL | Sell | 896 | $368.56 | $330K | −25.4% | Director |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | 17 | $11.7M |
Other insiders at MADRIGAL PHARMACEUTICALS, INC.
8 other tracked filers at MDGL.